Loading...
Date of Award
Spring 2020
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Michael Huber, MMS, PA-C, DFAAPA
Abstract
Obstructive sleep apnea (OSA) is a common comorbidity found in patients with Type 2 diabetes (T2DM) and has been identified as an independent risk factor in developing T2DM. Continuous positive airway pressure (CPAP) is the first line treatment for OSA. This study reviewed six articles that assessed the impact of CPAP treatment on glycemic control in patients with T2DM and OSA compared to no treatment. The results showed that CPAP does not lead to improved glycemic control in the short term but may be associated with a slower rise in hemoglobin A1c (HbA1c) in the long term. CPAP treatment led to significant improvements in blood pressure and sleep scores, supporting the use of CPAP in patients with T2DM and OSA regardless of its effect on HbA1c.
Recommended Citation
DebRoy, Whitney, "CPAP therapy on glycemic control in patients with obstructive sleep apnea and type 2 diabetes" (2020). Capstone Showcase. 18.
https://scholarworks.arcadia.edu/showcase/2020/pa/18
CPAP therapy on glycemic control in patients with obstructive sleep apnea and type 2 diabetes
Obstructive sleep apnea (OSA) is a common comorbidity found in patients with Type 2 diabetes (T2DM) and has been identified as an independent risk factor in developing T2DM. Continuous positive airway pressure (CPAP) is the first line treatment for OSA. This study reviewed six articles that assessed the impact of CPAP treatment on glycemic control in patients with T2DM and OSA compared to no treatment. The results showed that CPAP does not lead to improved glycemic control in the short term but may be associated with a slower rise in hemoglobin A1c (HbA1c) in the long term. CPAP treatment led to significant improvements in blood pressure and sleep scores, supporting the use of CPAP in patients with T2DM and OSA regardless of its effect on HbA1c.